CSPC PHARMACEUTGR Financials
| CVGU Stock | EUR 2.26 0.04 1.74% |
CSPC |
Understanding current and past CSPC PHARMACEUTGR Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CSPC PHARMACEUTGR's financial statements are interrelated, with each one affecting the others. For example, an increase in CSPC PHARMACEUTGR's assets may result in an increase in income on the income statement.
CSPC PHARMACEUTGR Stock Summary
CSPC PHARMACEUTGR competes with Ultra Clean, PARKEN Sport, Consolidated Communications, Bank of America, and Ribbon Communications. CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. CSPC PHARMACEUT operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21527 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US12591J2078 |
| Business Address | No 226 Huanghe |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | Dow Jones Industrial |
| Website | www.cspc.com.hk |
| Phone | 86 31 1870 37015 |
| Currency | EUR - Euro |
You should never invest in CSPC PHARMACEUTGR without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CSPC Stock, because this is throwing your money away. Analyzing the key information contained in CSPC PHARMACEUTGR's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CSPC PHARMACEUTGR Key Financial Ratios
There are many critical financial ratios that CSPC PHARMACEUTGR's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CSPC PHARMACEUTGR ADR4 reports annually and quarterly.| Beta | 0.75 | |||
| Z Score | 24.0 | |||
| Last Dividend Paid | 0.24 |
CSPC Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSPC PHARMACEUTGR's current stock value. Our valuation model uses many indicators to compare CSPC PHARMACEUTGR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSPC PHARMACEUTGR competition to find correlations between indicators driving CSPC PHARMACEUTGR's intrinsic value. More Info.CSPC PHARMACEUTGR ADR4 is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers reporting about 1.19 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSPC PHARMACEUTGR's earnings, one of the primary drivers of an investment's value.CSPC PHARMACEUTGR ADR4 Systematic Risk
CSPC PHARMACEUTGR's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CSPC PHARMACEUTGR volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on CSPC PHARMACEUTGR ADR4 correlated with the market. If Beta is less than 0 CSPC PHARMACEUTGR generally moves in the opposite direction as compared to the market. If CSPC PHARMACEUTGR Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CSPC PHARMACEUTGR ADR4 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CSPC PHARMACEUTGR is generally in the same direction as the market. If Beta > 1 CSPC PHARMACEUTGR moves generally in the same direction as, but more than the movement of the benchmark.
CSPC PHARMACEUTGR November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CSPC PHARMACEUTGR help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CSPC PHARMACEUTGR ADR4. We use our internally-developed statistical techniques to arrive at the intrinsic value of CSPC PHARMACEUTGR ADR4 based on widely used predictive technical indicators. In general, we focus on analyzing CSPC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CSPC PHARMACEUTGR's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.24 | |||
| Information Ratio | 0.041 | |||
| Maximum Drawdown | 43.46 | |||
| Value At Risk | (7.67) | |||
| Potential Upside | 8.7 |
Complementary Tools for CSPC Stock analysis
When running CSPC PHARMACEUTGR's price analysis, check to measure CSPC PHARMACEUTGR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC PHARMACEUTGR is operating at the current time. Most of CSPC PHARMACEUTGR's value examination focuses on studying past and present price action to predict the probability of CSPC PHARMACEUTGR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC PHARMACEUTGR's price. Additionally, you may evaluate how the addition of CSPC PHARMACEUTGR to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |